Título Añoorden ascendente
High Expression of KCa3.1 in Patients with Clear Cell Renal Carcinoma Predicts High Metastatic Risk and Poor Survival. 2015
Genetic deficit of KCa3.1 channels protects against pulmonary circulatory collapse induced by TRPV4 channel activation. 2015
Vascular dysfunctions in the isolated aorta of double-transgenic hypertensive mice developing aortic aneurysm. 2014
Pulmonary Hypertension in Wild Type Mice and Animals with Genetic Deficit in KCa2.3 and KCa3.1 Channels. 2014
A Novel Pan-negative-gating Modulator of KCa2/3 Channels, the Fluoro-di-benzoate, RA-2, Inhibits EDH-type Relaxation in Coronary Artery and Produces Bradycardia In Vivo. 2014
Preserved regulation of renal perfusion pressure by small and intermediate conductance KCa channels in hypertensive mice with or without renal failure. 2014
Expression of T-cell KV1.3 potassium channel correlates with pro-inflammatory cytokines and disease activity in ulcerative colitis. 2014
New Positive KCa Channel Gating Modulators with Selectivity for KCa3.1. 2014
Positive feedback regulation of agonist-stimulated endothelial Ca2+ dynamics by KCa3.1 channels in mouse mesenteric arteries. 2014
Modulation of KCa3.1 Channels by Eicosanoids, Omega-3 Fatty Acids, and Molecular Determinants. 2014
K+ -channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells. 2014
Activation of KCa 3.1 by SKA-31 induces arteriolar dilation and lowers blood pressure in normo- and hypertensive connexin40-deficient mice. 2013
Alterations of N-3 Polyunsaturated Fatty Acid-Activated K2P Channels in Hypoxia-Induced Pulmonary Hypertension. 2013
The potassium channel KCa3.1 as new therapeutic target for preventing obliterative airway disease after lung transplantation. 2013
Endothelial Small- and Intermediate-Conductance KCa Channels: An Update on Their Pharmacology and Usefulness as Cardiovascular Targets. 2013
Novel phenolic inhibitors of small/intermediate-conductance Ca2+-activated K+ channels, KCa3.1 and KCa2.3. 2013
Activation of endothelial and epithelial KCa2.3 calcium-activated potassium channels by NS309 relaxes human small pulmonary arteries and bronchioles. 2012
Heavy metal to lower the pressure? 2012
Nitric Oxide: Orchestrator of Endothelium-Dependent Responses. 2012
Genetic KCa3.1-deficiency produces locomotor hyperactivity and alterations in cerebral monoamine levels. 2012